Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics, Inc. (FULC) is a healthcare company (biotechnology) based in the United States. The share price is $3.73, up 0.40% on the day, which values the company at $284.52M. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$3.73+0.40% today
Market value
$284.52M
200-week average
$6.0639% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Fulcrum Therapeutics, Inc. in more detail

FULC trades at -6.5× next year's expected earnings. It sits 39% below its 200-week average of $6.06.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Fulcrum Therapeutics, Inc. (FULC): questions and answers

What is Fulcrum Therapeutics, Inc.'s market cap?

Fulcrum Therapeutics, Inc. is valued at $284.52M at a share price of $3.73.

Is FULC above its 200-week moving average?

No. FULC is 38.5% below its 200-week average of $6.06. Long-term investors watch that line because strong companies rarely trade below it for long.

Does FULC pay a dividend?

Fulcrum Therapeutics, Inc. does not currently pay a regular dividend.

When does Fulcrum Therapeutics, Inc. report earnings next?

Fulcrum Therapeutics, Inc.'s next earnings report is expected on November 16, 2026. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “Fulcrum Therapeutics, Inc. (FULC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/FULC

Underlying data: Yahoo Finance; company filings with the SEC.